About Altru Health System Research Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Altru Health System Research Center
During the past decade, Altru Health System Research Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)
2006-06-01
2008-06-01
Completed
218
Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)
2006-09-01
2009-06-01
Completed
330
Efficacy and Safety of SPD503 in Combination With Psychostimulants
2008-09-02
2009-12-10
Completed
461
Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl
2011-09-19
2013-05-16
Completed
314
Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)
2010-05-11
2013-06-03
Completed
528
Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate
2010-06-28
2012-07-19
Completed
267
Phase IV Long-term Maintenance Study of Aripiprazole in the Treatment of Irritability Associated With Autistic Disorder
2011-03-01
2012-06-01
Completed
215
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Altru Health System Research Center
According to Clinical.Site data, the most researched conditions in "Altru Health System Research Center" are
"Atrial Fibrillation" (2 trials), "Osteoporosis" (2 trials), "Chronic Renal Insufficiency" (1 trials), "Hyperphosphatemia" (1 trials) and "Renal Failure" (1 trials). Many other conditions were trialed in "Altru Health System Research Center" in a lesser frequency.
Clinical Trials Intervention Types at Altru Health System Research Center
Most popular intervention types in "Altru Health System Research Center" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Azimilide Dihydrochloride" (2 trials), "Placebo" (2 trials), "ALX1-11" (1 trials), "ALX1-11 (drug)" (1 trials) and "Hectorol (doxercalciferol capsules), 0.5mcg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Altru Health System Research Center
The vast majority of trials in "Altru Health System Research Center" are
4 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Altru Health System Research Center
Currently, there are NaN active trials in "Altru Health System Research Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Altru Health System Research Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Altru Health System Research Center, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".